NTRK3 and mucoepidermoid carcinoma: Of the AdCC cases, 82.5% scored positive, in SDC cases 77.5%, in MEC cases 53.3%, in AciCC cases 37.5% and in the miscellaneous group including the secretory carcinoma case with the ETV6-NTRK3 gene fusion all cases scored positive.